Contact Us

MEETING NEWS

CureGene Received Clinical Trial Approval in China for CG-0255 for Injection - A Novel Antiplatelet Therapy

Dec 18, 2024

SHANGHAI,Dec. 12,2024-- CureGene Pharmaceutical ("CureGene"),a biotechnology company dedicated to innovative treatments for critical unmet medical needs in cardio-cerebrovascular and antivir

Internet celeb videos fuel Hainan travel popularity surge

Dec 18, 2024

HAIKOU,China,Dec. 12,2024--A report fromHainan International Media Center (HIMC): This year,as Hainan\'s visa free policy continued to broaden easy access to the island province in south China,the num

Xinhua Silk Road: AI Expo opens in E. China's Suzhou Industrial Park to bolster high-tech growth drivers

Dec 18, 2024

BEIJING,Dec. 13,2024-- The 2024 Global AI Product & Application Expo,a 2-day event showcasing the latest AI technologies and products,kicked off in Suzhou Industrial Park (SIP) on Tuesday.

Mirae Asset Bolsters Suite of Fixed Income ETFs with its Global X US Treasury 0-3 Month ETF

Dec 18, 2024

TheGlobal X US Treasury 0-3 Month ETF (3440 / 9440)is the first short-term US T-bills ETF listed in Hong Kong

Midea Strengthens Global Presence in the Heat Pump Industry with Optimistic Market Outlook

Dec 18, 2024

FOSHAN,China,Dec. 13,2024-- In a recent exclusive interview withJARN,a leading Japanese HVAC industry publication,Peter Guan,Vice President of Midea Group and President of Midea Building Technologies

Transcenta Debuts Promising Anti-Tumor Activity of Novel LIV-1 Targeting ADCs with Site-Specific Conjugated Topo I Inhibitor Payload in TNBC Tumor Models at 2024 SABCS

Dec 18, 2024

PRINCETON,N.J. and SUZHOU,China,Dec. 13,2024-- Transcenta Holding Limited ("Transcenta") (HKEX: 06628),a global clinical stage biopharmaceutical company with fully-integrated capabilities in

1 ... 178 179 180 181 182 183 184 ... 358